Philip Joseph
At the second virtual European Society of Cardiology (ESC) Congress later this month, PHRI scientists will participate in the scientific program with the following live sessions:
PHRI Scientist Philip Joseph‘s presentation on Fixed dose combination therapies with or without aspirin in primary prevention of cardiovascular disease (polypill) will be part of Late Breaking Science in Prevention on Aug. 29.
Emilie Belley Cote
PHRI Investigator Emilie Belley-Cote will present on LAAOS III – surgical atrial fibrillation ablation evaluation, part of the Late Breaking Science in Arrhythmias, on Aug. 27.
Shamir Mehta
PHRI Senior Scientist Shamir Mehta will present on Nonculprit artery revascularization in STEMI: why, when, and when not? as part of the Meet the Experts: Difficult decisions in management of acute coronary syndromes, also on Aug. 28.
Sonia Anand
PHRI Senior Scientist Sonia Anand will present on Management of peripheral artery disease – an essential update on Aug. 28.
On demand: PHRI Scientist Darryl Leong will present on cardiovascular risk factors and COVID-19 (PURE SARS-CoV2).
Darryl Leong
McMaster cardiology resident, Ankit Garg, working with the ACS research team at PHRI, is presenting on TOTAL risk score for predicting safe very early discharge in patients with ST-elevation myocardial infarction (STEMI), in the live abstracts session, Acute Coronary Syndromes – diagnosis, treatment, outcomes.
